Novartis AG (NYSE: NVS) was raised to “equal-weight” from “underweight,” with its Swiss price target lifted to SFr 100 from ...

Switzerland, long admired for its calm diplomacy and strict neutrality, has just been hit by a harsh economic surprise. The ...

Switzerland’s president and other top officials are traveling to Washington in a hastily arranged trip aimed at striking a ...

Novartis AG is weighing a takeover of rare disease-focused biotech firm Avidity Biosciences Inc. in a bid to boost its drug ...

Punitive tariffs threatened by U.S. President Donald Trump have caused an uproar in Switzerland. How important are U.S.

39%? For Switzerland, this is a huge shock, and worse than the worst-case scenario – these are the highest tariffs in Europe.

US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug ...

The Swiss government said it had “no indication” the country would be hit with a 39 percent tariff, which is set to take ...

Its small size and neutrality proved to be no shield. Read more at straitstimes.com. Read more at straitstimes.com.

Switzerland's Novartis on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis (MS) drug.

Swiss drugmaker Novartis plans to cut up to 500 jobs in its pharmaceutical division and create new positions across several divisions as it frees up resources to help support the launch of new drugs.

Research outputs by subject area Subject Count Share Biological sciences 37 10.42 Chemistry 7 3.16 Health sciences 10 4.30 Physical sciences 5 2.27 ...